Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BioAge Labs, Inc. | Director | Common Stock | 1.27M | Oct 1, 2024 | AH Bio Fund I, L.P. | ||
BioAge Labs, Inc. | Director | Common Stock | 1.12M | Oct 3, 2024 | Andreessen Horowitz LSV Fund III, L.P. | ||
BioAge Labs, Inc. | Director | Common Stock | 655K | Oct 1, 2024 | AH Bio Fund IV, L.P. | ||
BioAge Labs, Inc. | Director | Common Stock | 190K | Oct 1, 2024 | AH Bio Fund III, L.P. | ||
Nautilus Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 45K | Jun 14, 2024 | Direct | ||
BioAge Labs, Inc. | Director | Series A-1 Preferred Stock | 0 | Sep 27, 2024 | AH Bio Fund I, L.P. | ||
BioAge Labs, Inc. | Director | Series B Preferred Stock | 0 | Sep 27, 2024 | AH Bio Fund I, L.P. | ||
BioAge Labs, Inc. | Director | Series C Preferred Stock | 0 | Sep 27, 2024 | AH Bio Fund III, L.P. | ||
BioAge Labs, Inc. | Director | Series D Preferred Stock | 0 | Sep 27, 2024 | AH Bio Fund IV, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BIOA | BioAge Labs, Inc. | Oct 1, 2024 | 3 | $4.33M | 4 | Oct 3, 2024 | Director |
BIOA | BioAge Labs, Inc. | Sep 27, 2024 | 9 | $16.2M | 4 | Sep 27, 2024 | Director |
BIOA | BioAge Labs, Inc. | Sep 25, 2024 | 0 | $0 | 3 | Sep 25, 2024 | Director |
NAUT | Nautilus Biotechnology, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
NAUT | Nautilus Biotechnology, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
NAUT | Nautilus Biotechnology, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
NAUT | Nautilus Biotechnology, Inc. | Jun 9, 2021 | 0 | $0 | 3 | Jun 9, 2021 | Director |